Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

ANIK Q3 2016 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$207M

Q3 2016 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$26M

Gross Profit

$21M80.6% margin

Operating Income

$14M53.1% margin

Net Income

$9M34.7% margin

EPS (Diluted)

$0.59

QoQ Revenue Growth

-3.0%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$9M

Stock-Based Comp.

$798,000

Balance Sheet

Total Assets

$231M

Total Liabilities

$17M

Stockholders' Equity

$215M

Cash & Equivalents

$98M

Geographic Segments

UNITED STATES

$21M89%

Europe

$3M11%

← FY 2016 All Quarters Q4 2016 →